Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

BioIntellisense Stock

Q: How to sell BioIntellisense stock?

If you hold private company shares of BioIntellisense - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your BioIntellisense stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

biointellisense.comHealthcare / Digital HealthFounded: 2018Funding to Date: $260.65MM

BioIntelliSense is a provider of continuous health monitoring and clinical intelligence solutions for Remote Patient Monitoring (RPM) and developer of a medical-grade Data-as-a-Service (DaaS) platform designed to seamlessly capturesminute-to-minute vital signs, physiological biometrics and symptomatic events through an effortless patient experience.

Buy or sell BioIntellisense stockLearn more about BioIntellisense IPO

OverviewFinancingsValuation

Enterprise Value

Access BioIntellisense’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like BioIntellisense.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

BioIntellisense stock FAQs

Can you buy BioIntellisense stock?

As BioIntellisense is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like BioIntellisense, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy BioIntellisense stock?

To invest in a private company like BioIntellisense through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell BioIntellisense stock?

Yes, you may be able to sell your BioIntellisense stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell BioIntellisense stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your BioIntellisense stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is BioIntellisense a public company?

No, BioIntellisense is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is BioIntellisense’s stock price?

BioIntellisense is a privately held company and therefore does not have a public stock price. However, you may access BioIntellisense’s private market stock price with Forge Data.

What is BioIntellisense’s stock ticker symbol?

BioIntellisense does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Vator News 11/17/2023

BioIntelliSense and UC Davis partner to remotely monitor oncology patients

BioIntelliSense has announced a continuation of its partnership with UC Davis Health, launching an in-hospital monitoring initiative for patients in need of bone marrow transplants and hematology/oncology services. Using the BioButton wearable device, the programme continuously monitors patients' vital signs, alerting clinicians to subtle shifts that may indicate potential deterioration, enabling faster, more proactive intervention. Early studies have shown that the BioButton improves clinical management of oncology patients. The companies plan to expand the initiative from in-hospital to at-home monitoring.

Vator News 05/05/2023

Dr. Jim Mault, founder and CEO of BioIntelliSense, on VatorNews podcast

BioIntelliSense CEO, Dr. Jim Mault, spoke on VatorNews podcast about the company's wearable device, BioButton, that offers continuous physiological monitoring of vital signs. He noted the device's evolution from a consumer wearable to a medical-grade product. The BioButton is designed to help address the shortage of healthcare workers by automating vital sign measurements, thereby reducing the need for bedside checks by nurses.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.